World / Cancer
06.09.2008 10:12
medicalnewstoday.com
Leading ovarian cancer researchers and clinicians from around the world gathered at the Ovarian Cancer Research Symposium today to hear about cutting-edge developments that may increase the chances of early detection of the disease. Dr. Patricia Kruk, from the University of South Florida, presented her research that could lead to using a non-invasive urine test for detecting ovarian cancer.
World
Cancer
06.09.2008 08:12
medicalnewstoday.com
Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) announced the initiation of the first clinical trial of TYSABRI® (natalizumab) in oncology. The first dose of TYSABRI was administered yesterday in the trial. The objectives of this Phase I/II study are to evaluate the safety and potential anti-tumor activity of TYSABRI in patients with relapsed or refractory multiple myeloma.
World
Cancer
06.09.2008 06:13
medicalnewstoday.com
Celgene Corporation (NASDAQ: CELG) announced that Amrubicin has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy.
World
Cancer
06.09.2008 04:11
medicalnewstoday.com
New research published in the Journal of the American College of Surgeons shows African Americans are more than twice as likely as Caucasians to die in the hospital after surgical removal of part of the liver -- an increasingly used procedure for the treatment of liver cancer. In recent years, a large body of evidence has emerged revealing significant racial disparities in health care and outcomes in the United States.
World
Cancer
English
Українська
Русский
Date: 06 September 2008 - 11:20
Number of sources in English: 130